“…Of note, in order to guide adherence in elements 7 and 8, an assessment tool, the Metacognition Assessment Scale -Abbreviated (MAS-A, Lysaker et al, 2005) is used to assess patient's metacognitive and therefore choose appropriate levels of intervention. Accumulating evidences for the effectiveness of this therapy comes from randomized controlled trials, qualitative studies and case reports (e.g., de Jong, Hasson-Ohayon, van Donkersgoed, Aleman, & Pijnenborg, 2018;de Jong et al, 2019;Lavi-Rotenberg et al, 2020;Vohs et al, 2018), but the application of it under global crisis context is only now taking place.…”